A Phase2 of A-101 Topical Solution in Subjects With Common Warts

Phase 2 Completed 157 enrolled Aclaris Therapeutics, Inc.

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.

Timeline

Start: 2017-08-01
Primary completion: 2018-03-16
Completion: 2018-03-16

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hydrogen Peroxide	Small molecule	—	Topical

A Phase2 of A-101 Topical Solution in Subjects With Common Warts

Summary

Timeline

Drugs

Indications